Medical Devices United States Bio-Pharma Market Report 2017 | Page 4

Table of Contents
In this report, the United States Bio-pharma market is valued at USD XX million in 2016 and is
expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between
2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
The Midwest
with sales (volume), revenue (value), market share and growth rate of Bio-pharma in these
regions, from 2012 to 2022 (forecast).
United States Bio-pharma market competition by top manufacturers/players, with Bio-
pharma sales volume, price, revenue (Million USD) and market share for each
manufacturer/player; the top players including
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen